Senior post-doc, Dr. Andrew Gibb’s newest work, a research letter, titled “Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure” was published in Circulation. This study identifies “glutaminolysis as a critical mediator of myofibroblast persistence in a murine model of HF and in CFs isolated directly from failing human hearts”.
Read the research letter here